Market Closed

NKTR
Nektar Therapeutics
$ 37.27
0.05%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

Nektar Therapeutics News

Latest Nektar Therapeutics Stock News & NKTR Headlines

NKTR Q3 Earnings Beat Estimates, 2026 Revenue View Cut, Stock Down
2 days ago | zacks.com
Nektar Therapeutics (NKTR) Q3 2026 Earnings Call Transcript
2 days ago | seekingalpha.com
What Nektar Therapeutics (NKTR) Said on Its Q3 Earnings Call
2 days ago | marketbeat.com
Nektar Therapeutics (NKTR) Reports Q3 Loss, Lags Revenue Estimates
2 days ago | zacks.com
Nektar Therapeutics Announces Third Quarter 2026 Financial Results
2 days ago | prnewswire.com
Nektar Therapeutics to Participate in Two Investor Conferences in November
3 days ago | prnewswire.com
CenterBook Partners LP Buys 26,346 Shares of Nektar Therapeutics $NKTR
5 days ago | defenseworld.net
Nektar Therapeutics: Focus Returns To The Strengths Of The Company
16 days ago | seekingalpha.com
Nektar Therapeutics (NKTR) Expected to Beat Earnings Estimates: Should You Buy?
17 days ago | zacks.com
Nektar Therapeutics to Announce Financial Results for the Third Quarter on Thursday, November 12, 2026, After Close of U.S.-Based Financial Markets
18 days ago | prnewswire.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

NKTR
Nektar Therapeutics
$ 37.27
0.05%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago